Cross-sectional evaluation of a clinical decision support tool to identify medication-related problems at discharge from the acute care setting

IF 1.3 Q4 PHARMACOLOGY & PHARMACY Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-06-26 DOI:10.1002/jac5.1998
Savanna DiCristina Pharm.D., MPH, Jacques Turgeon Ph.D., Veronique Michaud Ph.D., Luigi Brunetti Pharm.D., Ph.D.
{"title":"Cross-sectional evaluation of a clinical decision support tool to identify medication-related problems at discharge from the acute care setting","authors":"Savanna DiCristina Pharm.D., MPH,&nbsp;Jacques Turgeon Ph.D.,&nbsp;Veronique Michaud Ph.D.,&nbsp;Luigi Brunetti Pharm.D., Ph.D.","doi":"10.1002/jac5.1998","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>There are many reported pharmacist-led transitions of care (TOC) programs to address medication-related problems (MRP) at discharge from the acute care setting. Most have identified time and labor resources as significant limitations. This study aims to assess the effectiveness of a medication risk score (MRS)-driven clinical decision support system (CDSS) in identifying actionable MRPs and improving medication safety in the acute care discharge TOC setting.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A cross-sectional analysis was conducted in a cohort of 481 subjects discharged from the acute care setting. The MRS-CDSS was utilized to identify MRPs and provide recommendations for risk reduction. The distribution of MRPs, recommendations, and their associations with MRS severity were analyzed. Additionally, the potential reduction in MRS per subject and its correlation with MRS severity were examined.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The median MRS reduction per subject was 2 points, while high/severe-risk patients showed a median potential reduction of 7 points. Among the identified MRPs (<i>n</i> = 691), drug interaction, drug use without indication, and adverse drug reaction accounted for 89.7% of all MRPs. The top three recommendations, discontinue medication, change the time of administration, and start alternative therapy, represented 94.1% of all recommendations. Stratified analysis by MRS category revealed a significant increase in adverse drug reaction MRPs and recommendations to discontinue medications with higher MRS severity. The results were consistent with previous outpatient studies, supporting the MRS-CDSS's ability to enhance medication safety.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This study demonstrates that the MRS-CDSS effectively identifies actionable MRPs and has the potential to substantially reduce overall pharmacotherapy regimen risk when applied during acute care discharge TOC. The findings support implementable recommendations directed at patient safety and the allocation of health care resources to high-risk patients for maximum benefit.</p>\n </section>\n </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1998","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1998","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

There are many reported pharmacist-led transitions of care (TOC) programs to address medication-related problems (MRP) at discharge from the acute care setting. Most have identified time and labor resources as significant limitations. This study aims to assess the effectiveness of a medication risk score (MRS)-driven clinical decision support system (CDSS) in identifying actionable MRPs and improving medication safety in the acute care discharge TOC setting.

Methods

A cross-sectional analysis was conducted in a cohort of 481 subjects discharged from the acute care setting. The MRS-CDSS was utilized to identify MRPs and provide recommendations for risk reduction. The distribution of MRPs, recommendations, and their associations with MRS severity were analyzed. Additionally, the potential reduction in MRS per subject and its correlation with MRS severity were examined.

Results

The median MRS reduction per subject was 2 points, while high/severe-risk patients showed a median potential reduction of 7 points. Among the identified MRPs (n = 691), drug interaction, drug use without indication, and adverse drug reaction accounted for 89.7% of all MRPs. The top three recommendations, discontinue medication, change the time of administration, and start alternative therapy, represented 94.1% of all recommendations. Stratified analysis by MRS category revealed a significant increase in adverse drug reaction MRPs and recommendations to discontinue medications with higher MRS severity. The results were consistent with previous outpatient studies, supporting the MRS-CDSS's ability to enhance medication safety.

Conclusion

This study demonstrates that the MRS-CDSS effectively identifies actionable MRPs and has the potential to substantially reduce overall pharmacotherapy regimen risk when applied during acute care discharge TOC. The findings support implementable recommendations directed at patient safety and the allocation of health care resources to high-risk patients for maximum benefit.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对临床决策支持工具进行横断面评估,以确定急诊出院时与用药相关的问题
背景 据报道,有许多以药剂师为主导的护理过渡(TOC)计划,旨在解决急症护理出院时的用药相关问题(MRP)。大多数计划都将时间和人力作为主要限制因素。本研究旨在评估由用药风险评分(MRS)驱动的临床决策支持系统(CDSS)在识别可操作的 MRP 和改善急症护理出院 TOC 环境中用药安全方面的有效性。 方法 对 481 名急诊出院者进行了横断面分析。MRS-CDSS 用于识别 MRPs 并提供降低风险的建议。分析了 MRP 的分布、建议及其与 MRS 严重程度的关系。此外,还研究了每个受试者可能减少的 MRS 量及其与 MRS 严重程度的相关性。 结果 每个受试者的 MRS 降低幅度中位数为 2 分,而高风险/严重风险患者的潜在降低幅度中位数为 7 分。在已确定的 MRP(n = 691)中,药物相互作用、无适应症用药和药物不良反应占所有 MRP 的 89.7%。停药、改变给药时间和开始替代疗法这三项建议占所有建议的 94.1%。按 MRS 类别进行的分层分析显示,药物不良反应 MRP 和停药建议在 MRS 严重程度较高时显著增加。结果与之前的门诊研究一致,证明 MRS-CDSS 有能力提高用药安全。 结论 本研究表明,MRS-CDSS 可有效识别可操作的 MRP,并有可能在急诊出院 TOC 中应用,从而大幅降低整体药物治疗方案的风险。研究结果支持针对患者安全和将医疗资源分配给高风险患者以实现最大利益的可实施建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Connecting medication therapy problems with social determinants of health: A proposed framework Collaborative leadership exists within all our scopes of practice Part I: Case series: Pancreatitis Part II: Recorded webcast: Vaping
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1